Skip to main content
. 2020 Oct 19;185(2):293–305. doi: 10.1007/s10549-020-05955-1

Fig. 3.

Fig. 3

Patients’ outcomes of Breast cancer survival on Proteomic level. a Cumulative survival of BC patients stratified by ISG15 protein expression in the Nottingham cohort. b Cumulative survival of BC patients stratified by ISG15 protein expression in the Nottingham LVI-positive cohort. c Cumulative survival of BC patients stratified by ISG15 protein expression in the Nottingham HER2-positive cohort